Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1998 | 09-1998 | 06-1998 | 03-1998 | |
| Gross Profit | 2,410 | 1,860 | 1,930 | 1,430 |
| Operating Expenses | 7,580 | 5,720 | 5,060 | 4,640 |
| Operating Income | -7,580 | -5,720 | -5,060 | -4,640 |
| Pre-tax Income | -7,580 | -5,720 | -5,060 | -4,640 |
| Net Income Continuous | -7,580 | -5,720 | -5,060 | -4,640 |
| Net Income | $-7,580 | $-5,720 | $-5,060 | $-4,640 |
| EBITDA(a) | $-6,830 | $-4,910 | $-4,270 | $-3,650 |